Global Aspirin Market Size To Worth USD 3133.40 Million By 2033 | CAGR Of 2.62%
Category: HealthcareGlobal Aspirin Market Size To Worth USD 3133.40 Million By 2033 | CAGR Of 2.62%
According to a research report published by Spherical Insights & Consulting, the Global Aspirin Market Size is Expected to Grow from USD 2420.12 Million in 2023 to USD 3133.40 Million by 2033, at a CAGR of 2.62% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 205 pages with 111 Market data tables and figures & charts from the report on the "Global Aspirin Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Injections, Capsules, and Tablets), By Product (Prescription and Over-the-Counter (OTC)), By Application (Cardiovascular Diseases, Inflammation, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/aspirin-market
The aspirin market focuses on the development, production, and commercialization of aspirin, a non-steroidal anti-inflammatory agent and anti-platelet drug. Aspirin, a trademark owned by Bayer, is used to reduce fever and mild to moderate pain from various conditions, including muscle aches, toothaches, common colds, headaches, and arthritis. It works by blocking a natural substance in the body, and low doses may be prescribed to prevent blood clots, stroke, and heart attacks. Aspirin is increasingly used to treat and prevent heart attacks and strokes due to the increasing prevalence of these disorders globally. Technological advancements in drug delivery systems have enabled the creation of aspirin formulations with variable release times, improving patient adherence and supporting the market's expansion. The aspirin market is growing due to the rise in cardiovascular diseases, leading to increased use of low-dose aspirin for heart attacks and strokes. Medical research is expanding its use to new therapeutic areas, and the aging population is more susceptible to chronic conditions like cardiovascular diseases and arthritis. The convenience of retail and online pharmacies and research into aspirin's potential role in cancer prevention and inflammatory conditions also contribute to market expansion. However, the side effects of the aspirin may impede the market growth.
The tablets segment held the largest share of 62.83% in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dosage form, the global aspirin market is categorized as injections, capsules, and tablets. Among these, the tablets segment held the largest share of 62.83% in 2023 and is predicted to grow at a significant CAGR during the predicted period. Tablets are expanding due to their efficacy, rapid action, ease of administration, stability, extended shelf-life, enhanced bioavailability, cost-effectiveness, and availability in controlled-release tablets. They are suitable for pediatric and geriatric populations due to sugar and film coating.
The over-the-counter segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the product, the global aspirin market is categorized as prescription and over-the-counter (OTC). Among these, the over-the-counter segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of the segment is driven by the rise in common allergies, the popularity of online pharmacies, cost-effectiveness, and the rise in lifestyle diseases.
The inflammation segment held the highest growth rate in 2023.
Based on the application, the global aspirin market is categorized as inflammation, cardiovascular diseases, and others. Among these, the inflammation segment held the highest growth rate in 2023. The growth of this segment is attributed to the rise in inflammatory diseases like arthritis and psoriasis, where aspirin effectively relieves inflammation with a low dose.
North America is expected to hold the greatest share of the global aspirin market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global aspirin market over the forecast period. The market growth in this region is driven by increased demand for anti-inflammatory drugs, rising cardiovascular disease cases, common colds, and flu among Americans, leading in aspirin sales, innovations in drug delivery, numerous manufacturing companies, and growing awareness of cardiovascular diseases among citizens.
Asia Pacific is predicted to hold the fastest-growing region of the global aspirin market throughout the estimated period. The Asia-Pacific region is predicted to see the highest growth in the global aspirin market due to its robust pharmaceutical industry, particularly in China and India. These nations are world leaders in producing Active Pharmaceutical Ingredients (APIs) and cater to global drug manufacturers. Asia's large population base and densely populated regions contribute to higher sales of basic medicines like aspirin, while the expansion of OTC pharmacies and increased healthcare expenditure further drive market growth.
Major key players in the global aspirin market are Bal Pharma Limited, Umang Pharmatech Pvt. Ltd., Mayne Pharma Group Limited, Par Pharmaceutical, Cardinal Health, Globela Pharma Pvt. Ltd, Allegiant Health, LNK International, Inc., Perrigo Company plc, Anastacio Chemistry, Trumac Healthcare, Bayer AG, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In February 2025, on the occasion of Bayer’s 125th anniversary of the aspirin discovery, Bayers focused and developed innovative approaches to cardiovascular health, and aimed to increase access to personalized care and prevent cardiovascular disease. This research emphasized viewing cardiovascular risk as a continuum and using affordable tools such as Carotid Ultrasound to assess individual risk, enhancing treatment options of aspirin. This research was supported by a Bayer grant.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global aspirin market based on the below-mentioned segments:
Global Aspirin Market, By Dosage form
- Injections
- Capsules
- Tablets
Global Aspirin Market, By Product
- Prescription
- Over-the-Counter (OTC)
Global Aspirin Market, By Application
- Cardiovascular diseases
- Inflammation
- Others
Global Aspirin Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?